1. Market Research
  2. > Wuxi MTLH Biotechnology Co. Ltd. - Product Pipeline Review - 2013

Wuxi MTLH Biotechnology Co. Ltd. - Product Pipeline Review - 2013

  • December 2013
  • -
  • Global Markets Direct
  • -
  • 21 pages

Wuxi MTLH Biotechnology Co. Ltd. - Product Pipeline Review - 2013

Summary

Global Market Direct’s pharmaceuticals report, “Wuxi MTLH Biotechnology Co. Ltd. - Product Pipeline Review - 2013” provides data on the Wuxi MTLH Biotechnology Co. Ltd.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Wuxi MTLH Biotechnology Co. Ltd.’s corporate website, SEC filings, investor presentations and featured press releases, both from Wuxi MTLH Biotechnology Co. Ltd. and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Wuxi MTLH Biotechnology Co. Ltd. - Brief Wuxi MTLH Biotechnology Co. Ltd. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Wuxi MTLH Biotechnology Co. Ltd. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Wuxi MTLH Biotechnology Co. Ltd. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Wuxi MTLH Biotechnology Co. Ltd.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Wuxi MTLH Biotechnology Co. Ltd.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Wuxi MTLH Biotechnology Co. Ltd. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Wuxi MTLH Biotechnology Co. Ltd.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Wuxi MTLH Biotechnology Co. Ltd..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Wuxi MTLH Biotechnology Co. Ltd. and identify potential opportunities in those areas.

Table Of Contents

Wuxi MTLH Biotechnology Co. Ltd. - Product Pipeline Review - 2013
Table of Contents

Table of Contents 2
List of Tables 3
List of Figures 3
Wuxi MTLH Biotechnology Co. Ltd. Snapshot 4
Wuxi MTLH Biotechnology Co. Ltd. Overview 4
Key Information 4
Key Facts 4
Wuxi MTLH Biotechnology Co. Ltd. - Research and Development Overview 5
Key Therapeutic Areas 5
Wuxi MTLH Biotechnology Co. Ltd. - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
Wuxi MTLH Biotechnology Co. Ltd. - Pipeline Products Glance 9
Wuxi MTLH Biotechnology Co. Ltd. - Early Stage Pipeline Products 9
Preclinical Products/Combination Treatment Modalities 9
Discovery Products/Combination Treatment Modalities 10
Wuxi MTLH Biotechnology Co. Ltd. - Drug Profiles 11
MTLH-001 11
Product Description 11
Mechanism of Action 11
RandD Progress 11
MTLH-002 12
Product Description 12
Mechanism of Action 12
RandD Progress 12
MTLH-003 13
Product Description 13
Mechanism of Action 13
RandD Progress 13
MTLH-004 14
Product Description 14
Mechanism of Action 14
RandD Progress 14
Wuxi MTLH Biotechnology Co. Ltd. - Pipeline Analysis 15
Wuxi MTLH Biotechnology Co. Ltd. - Pipeline Products by Therapeutic Class 15
Wuxi MTLH Biotechnology Co. Ltd. - Pipeline Products by Target 16
Wuxi MTLH Biotechnology Co. Ltd. - Pipeline Products by Molecule Type 17
Wuxi MTLH Biotechnology Co. Ltd. - Pipeline Products by Mechanism of Action 18
Wuxi MTLH Biotechnology Co. Ltd. - Locations And Subsidiaries 19
Head Office 19
Appendix 20
Methodology 20
Coverage 20
Secondary Research 20
Primary Research 20
Expert Panel Validation 20
Contact Us 21
Disclaimer 21



List of Tables

Wuxi MTLH Biotechnology Co. Ltd., Key Information 4
Wuxi MTLH Biotechnology Co. Ltd., Key Facts 4
Wuxi MTLH Biotechnology Co. Ltd. - Pipeline by Indication, 2013 6
Wuxi MTLH Biotechnology Co. Ltd. - Pipeline by Stage of Development, 2013 7
Wuxi MTLH Biotechnology Co. Ltd. - Monotherapy Products in Pipeline, 2013 8
Wuxi MTLH Biotechnology Co. Ltd. - Preclinical, 2013 9
Wuxi MTLH Biotechnology Co. Ltd. - Discovery, 2013 10
Wuxi MTLH Biotechnology Co. Ltd. - Pipeline by Therapeutic Class, 2013 15
Wuxi MTLH Biotechnology Co. Ltd. - Pipeline by Target, 2013 16
Wuxi MTLH Biotechnology Co. Ltd. - Pipeline by Molecule Type, 2013 17
Wuxi MTLH Biotechnology Co. Ltd. - Pipeline Products by Mechanism of Action, 2013 18



List of Figures

Wuxi MTLH Biotechnology Co. Ltd. - Pipeline by Top 10 Indication, 2013 6
Wuxi MTLH Biotechnology Co. Ltd. - Pipeline by Stage of Development, 2013 7
Wuxi MTLH Biotechnology Co. Ltd. - Monotherapy Products in Pipeline, 2013 8
Wuxi MTLH Biotechnology Co. Ltd. - Pipeline by Top 10 Therapeutic Class, 2013 15
Wuxi MTLH Biotechnology Co. Ltd. - Pipeline by Top 10 Target, 2013 16
Wuxi MTLH Biotechnology Co. Ltd. - Pipeline by Top 10 Molecule Type, 2013 17
Wuxi MTLH Biotechnology Co. Ltd. - Pipeline Products by Top 10 Mechanism of Action, 2013 18



Companies Mentioned

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.